APA (7th ed.) Citation

E, T., S, D. M., C, M., GM, B., U, G., G, T., . . . GL, C. (2024). Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives. ClinicoEconomics and outcomes research : CEOR, 16, 773. https://doi.org/10.2147/CEOR.S472446

Chicago Style (17th ed.) Citation

E, Torre, Di Matteo S, Martinotti C, Bruno GM, Goglia U, Testino G, Rebora A, Bottaro LC, and Colombo GL. "Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives." ClinicoEconomics and Outcomes Research : CEOR 16 (2024): 773. https://doi.org/10.2147/CEOR.S472446.

MLA (9th ed.) Citation

E, Torre, et al. "Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives." ClinicoEconomics and Outcomes Research : CEOR, vol. 16, 2024, p. 773, https://doi.org/10.2147/CEOR.S472446.